|Bid||0.1800 x 0|
|Ask||0.1850 x 0|
|Day's Range||0.1800 - 0.1950|
|52 Week Range||0.1300 - 0.8850|
|Beta (5Y Monthly)||1.78|
|PE Ratio (TTM)||N/A|
|Earnings Date||Sep 24, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
IRVING, Texas, June 29, 2022--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2023 financial results after market close on Wednesday, August 3, 2022. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
These are the healthcare stocks with the best value, fastest growth, and most momentum for July 2022.
HCA Healthcare Inc. and McKesson Corporation are joining research forces. The two health care giants have agreed to form a joint venture combining McKesson subsidiary US Oncology Research and HCA’s Sarah Cannon Research Institute, according to a news release. Dallas-based McKesson will own 51% of the joint venture and possess operating control.